Charles C. Williams

3.1k total citations
83 papers, 2.1k citations indexed

About

Charles C. Williams is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Charles C. Williams has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Charles C. Williams's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (21 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Charles C. Williams is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (21 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Charles C. Williams collaborates with scholars based in United States, United Kingdom and Germany. Charles C. Williams's co-authors include Gerold Bepler, George R. Simon, Eric B. Haura, Alberto Chiappori, Scott Antonia, Tawee Tanvetyanon, Gary H. Lyman, Lary A. Robinson, Jhanelle E. Gray and Roohi Ismail‐Khan and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Charles C. Williams

80 papers receiving 2.0k citations

Peers

Countries citing papers authored by Charles C. Williams

Since Specialization

Citations

This map shows the geographic impact of Charles C. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles C. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles C. Williams more than expected).

Fields of papers citing papers by Charles C. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles C. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles C. Williams. The network helps show where Charles C. Williams may publish in the future.

Co-authorship network of co-authors of Charles C. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Charles C. Williams. A scholar is included among the top collaborators of Charles C. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles C. Williams. Charles C. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initiatives to increase breast and cervical cancer–related knowledge, screening, and health behaviours among Black women 2024 ·Canadian Journal of Public Health ·Charles C. Williams, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ruth Heisey, Aïsha Lofters	1
2	The Influence of Shoe and Cleat Type on Lower Extremity Muscle Activation in Youth Baseball Pitchers 2022 ·International Journal of Kinesiology and Sports Science ·(unknown), Chip Wade, (unknown), Charles C. Williams, (unknown), John C. Garner	0
3	Impact of Hydration Status on Jump Performance in Recreationally Trained Males 2020 ·International journal of exercise science ·(unknown), (unknown), Charles C. Williams, Christopher M. Hill, (unknown), John C. Garner	5
4	P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC 2018 ·Journal of Thoracic Oncology ·Alberto Chiappori, Charles C. Williams, Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, (unknown), (unknown), Amer A. Beg, (unknown), (unknown), (unknown), (unknown), Felipe K. Hurtado, Lucio Manenti, (unknown), Scott Antonia	9
5	Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer 2018 ·Cancer Immunology Immunotherapy ·Alberto Chiappori, Charles C. Williams, Jhanelle E. Gray, Tawee Tanvetyanon, Eric B. Haura, Ben Creelan, Ram Thapa, Dung‐Tsa Chen, George R. Simon, Gerold Bepler, Dmitry I. Gabrilovich, Scott Antonia	50
6	Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program 2017 ·Patient Education and Counseling ·Gwendolyn P. Quinn, Rebecca D. Pentz, Teresita Muñoz-Antonia, Theresa A. Boyle, Matthew B. Schabath, Charlotte B. Pratt, (unknown), (unknown), (unknown), Scott Antonia, Alberto Chiappori, Ben Creelan, Jhanelle E. Gray, Charles C. Williams, Eric B. Haura	2
7	Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors 2017 ·OncoTargets and Therapy ·Ben Creelan, Dmitry I. Gabrilovich, Jhanelle E. Gray, Charles C. Williams, Tawee Tanvetyanon, Eric B. Haura, Jeffrey S. Weber, Geoffrey T. Gibney, Joseph Markowitz, Joel W. Proksch, Scott A. Reisman, Mark D. McKee, Melanie Chin, Colin J. Meyer, (unknown)	41
8	Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib 2015 ·Cancer ·Peter Reichardt, Yoon‐Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S. Rosen, Beatrice Seddon, Şuayib Yalçın, Hans Gelderblom, Charles C. Williams, Elena Fumagalli, Guido Biasco, Herbert I. Hurwitz, (unknown), Kolette D. Fly, Ewa Matczak, (unknown), María José Lechuga, George D. Demetri	85
9	Phase 2 Study of Concurrent Cetuximab Plus Definitive Thoracic Radiation Therapy Followed by Consolidation Docetaxel Plus Cetuximab in Poor Prognosis or Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Thomas J. Dilling, Martine Extermann, Jongphil Kim, Lora M.A. Thompson, Binglin Yue, Craig Stevens, Scott Antonia, Jhanelle E. Gray, Charles C. Williams, Eric B. Haura, Mary Pinder-Schenck, Tawee Tanvetyanon, Sungjune Kim, Alberto Chiappori	10
10	Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma 2013 ·Journal of Immunotherapy ·Ben Creelan, Scott Antonia, David Noyes, Terri Hunter, George R. Simon, Gerold Bepler, Charles C. Williams, Tawee Tanvetyanon, Eric B. Haura, Michael J. Schell, Alberto Chiappori	28
11	Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Gerold Bepler, Thomas J. Dilling, Henry Wagner, Todd R. Hazelton, Charles C. Williams, Dung‐Tsa Chen, Harvey Greenberg, Frank Walsh, George R. Simon, Tawee Tanvetyanon, Alberto Chiappori, Eric B. Haura, Craig Stevens	7
12	A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors 2011 ·Cancer Chemotherapy and Pharmacology ·George R. Simon, Robert Ilaria, Mika A. Sovak, Charles C. Williams, Eric B. Haura, Ann Cleverly, (unknown), M M Wagner, Dinesh P. de Alwis, Christopher A. Slapak, (unknown), David R. Spriggs	17
13	Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer 2008 ·Journal of Thoracic Oncology ·Gerold Bepler, K. Eric Sommers, Alan Cantor, Xueli Li, Anupama Sharma, Charles C. Williams, Alberto Chiappori, Eric B. Haura, Scott Antonia, Tawee Tanvetyanon, George R. Simon, Coleman K. Obasaju, Lary A. Robinson	86
14	A message of hope: creation of theFaces of Lung Cancerproject for increasing awareness of clinical trials 2008 ·European Journal of Cancer Care ·Gwendolyn P. Quinn, Bethany A. Bell-Ellison, (unknown), (unknown), (unknown), (unknown), (unknown), Benjamin R. Reynolds, (unknown), (unknown), (unknown), Carlos Shimizu, Susan T. Vadaparampil, (unknown), Charles C. Williams, Gerold Bepler	5
15	Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer 2007 ·Journal of Clinical Oncology ·George R. Simon, Anupama Sharma, Xueli Li, Todd R. Hazelton, Frank Walsh, Charles C. Williams, Alberto Chiappori, Eric B. Haura, Tawee Tanvetyanon, Scott Antonia, Alan Cantor, Gerold Bepler	147
16	The Guinea Pig Syndrome: Improving Clinical Trial Participation among Thoracic Patients 2007 ·Journal of Thoracic Oncology ·Gwendolyn P. Quinn, Bethany A. Bell, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Charles C. Williams, Gerold Bepler	38
17	Spectral Analysis and Isostasy of the Alpha-Mendeleev Ridge, Arctic Ocean 2005 ·AGU Fall Meeting Abstracts ·Charles C. Williams, Bernard Coakley	2
18	Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer 2005 ·Oncology ·Alberto Chiappori, George R. Simon, Charles C. Williams, Eric B. Haura, Caio Rocha‐Lima, Henry Wagner, Gerold Bepler, Scott Antonia	23
19	Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary? 1999 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Ola Holmberg, Brendan McClean, Charles C. Williams, (unknown), Philip Sutton, John Armstrong	31
20	Chronic Calcium Antagonist Use in Carcinoma of the Lung and Colon: A Retrospective Cohort Observational Study 1990 ·Cancer Investigation ·Leo R. Zacharski, Thomas Moritz, Clair Haakenson, Joseph F. O’Donnell, Harold S. Ballard, Gerhard J. Johnson, Q. Scott Ringenberg, Richard L. Schilsky, Monica B. Spaulding, Karl Tornyos, Charles C. Williams	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact